Amrize (NYSE:AMRZ) Lowered to “Sell” Rating by Wall Street Zen

Wall Street Zen downgraded shares of Amrize (NYSE:AMRZFree Report) from a hold rating to a sell rating in a report released on Saturday.

A number of other research firms have also issued reports on AMRZ. Bank of America set a $58.00 target price on shares of Amrize in a report on Monday, January 12th. Citigroup raised their target price on shares of Amrize from $63.00 to $67.00 and gave the stock a “buy” rating in a research report on Thursday, January 8th. Weiss Ratings raised Amrize from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Wednesday, February 11th. UBS Group lifted their price objective on Amrize from $53.00 to $57.00 and gave the company a “neutral” rating in a research report on Thursday, January 8th. Finally, Berenberg Bank set a $70.00 target price on Amrize in a research note on Thursday. One equities research analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating and six have given a Hold rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $63.43.

Read Our Latest Research Report on AMRZ

Amrize Stock Up 1.8%

Shares of NYSE:AMRZ opened at $65.06 on Friday. Amrize has a fifty-two week low of $44.12 and a fifty-two week high of $65.26. The company has a quick ratio of 0.97, a current ratio of 1.64 and a debt-to-equity ratio of 0.37. The firm’s 50-day simple moving average is $56.08 and its 200-day simple moving average is $52.50. The company has a market cap of $35.98 billion and a price-to-earnings ratio of 35.36.

Amrize (NYSE:AMRZGet Free Report) last released its quarterly earnings data on Tuesday, February 17th. The company reported $0.62 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.59 by $0.03. The business had revenue of $2.84 billion during the quarter, compared to analysts’ expectations of $2.95 billion. The company’s revenue for the quarter was down .4% compared to the same quarter last year.

Institutional Investors Weigh In On Amrize

Several hedge funds and other institutional investors have recently bought and sold shares of AMRZ. Public Sector Pension Investment Board lifted its stake in shares of Amrize by 8.8% in the third quarter. Public Sector Pension Investment Board now owns 306,957 shares of the company’s stock worth $14,811,000 after buying an additional 24,738 shares during the last quarter. Norges Bank acquired a new position in shares of Amrize during the 2nd quarter worth about $670,915,000. Vanguard Group Inc. acquired a new stake in Amrize in the 2nd quarter valued at approximately $1,065,029,000. Prudential PLC bought a new stake in shares of Amrize in the second quarter valued at approximately $754,000. Finally, Dodge & Cox bought a new position in Amrize during the second quarter worth $622,085,000.

About Amrize

(Get Free Report)

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.

Recommended Stories

Analyst Recommendations for Amrize (NYSE:AMRZ)

Receive News & Ratings for Amrize Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amrize and related companies with MarketBeat.com's FREE daily email newsletter.